ILY-104

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameILY-104
Drug Alias NameILY-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypercholesterolemiaDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesI.L.Y. Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesI.L.Y. SaAmgen Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A